Cancer Tech Startup Ezra Raised $18 Million Right Before The Pandemic, Now It’s Pivoting To Covid-19 Screening

Funding Rounds

Summary

In late December, as the coronavirus raged in Wuhan, China—and was preparing its deadly jump to Europe and the US—cancer screening startup Ezra Health closed an $18 million deal. New Yorks FirstMark Captial lead the series A round that also included high-profile entrepreneurs like Vlad Tenev (Robinhood), Dave Gilboa (Warby Parker), Jeff Raider (Harrys). Based in New York and founded Emi Gal and Diego Cantor, Ezra developed AI-powered software that boosted the efficiency of existing MRI machines. A traditional cancer body scan can cost up to $10,000 and require a patient to lie in the tight MRI tube for more than three hours. Gal, 34, was planning to use the new cash to build new AI programs and expand to more cities (Ezra partnered with imaging company RadNet and is available in New York, LA, and San Francisco).

$ Funding

$
Amount $18.0M Total raised
Date June 1, 2020 Announcement date
Investors NPR Lead investors
Company - Funded company

Classifications

industries
No industries detected
applications
No applications detected

AskAI Classifications

Labels
No AI classifications detected

Linked Companies